Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions
Ductal Carcinoma in Situ
Interventions
PROCEDURE

Cryoablation

The cryoprobe tip will be inserted into the breast and directed under ultrasound guidance to the location where the ultrasound visible marker is located. Next, the cryoprobe will be used to freeze a 4 X 3 X 3 cm diameter area of DCIS using two separate 10-minute freeze cycles separated by a single 10-minute thaw cycle. The cryoprobe will remain in place the entire time. After the second freeze, the cryoprobe will be withdrawn from the breast and a bandage will be applied to the skin.

Trial Locations (1)

91206

RECRUITING

Office of Dennis R. Holmes, M.D., F.A.C.S., Glendale

All Listed Sponsors
collaborator

Helen Rey Breast Cancer Research Foundation

UNKNOWN

collaborator

California Oncology Research Institute

UNKNOWN

collaborator

Doterra Healing Hands Foundation

UNKNOWN

lead

Glendale Adventist Medical Center d/b/a Adventist Health Glendale

OTHER